NCT03031210 is a Phase 2, PHASE3 clinical trial of Amoxicillin in Community-acquired Pneumonia, sponsored by St. Justine's Hospital.

Who is sponsoring NCT03031210?

NCT03031210 is sponsored by St. Justine's Hospital.

What drugs are being tested in NCT03031210?

Interventions in NCT03031210: Amoxicillin.

What condition does NCT03031210 study?

NCT03031210 studies Community-acquired Pneumonia.

Is NCT03031210 still recruiting?

NCT03031210 is currently recruiting now. Last updated 14 May 2025.

Last reviewed 2025-05-14 · How we verify

NCT03031210

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

Recruiting now Phase 2, PHASE3 Last updated 14 May 2025

What this trial tests

Phase 2, PHASE3 trial testing Amoxicillin in Community-acquired Pneumonia in 1,370 participants. Currently enrolling.

Timeline

11 June 2017

Primary endpoint
1 June 2027

1 June 2027

Quick facts

Lead sponsor	St. Justine's Hospital
Phase	Phase 2, PHASE3
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	1,370
Start date	11 June 2017
Primary completion	1 June 2027
Estimated completion	1 June 2027
Sites	1 location across Canada

Drugs / interventions tested

Amoxicillin (amoxicillin) — full drug profile →

Conditions studied

Community-acquired Pneumonia — all drugs for Community-acquired Pneumonia →

Sponsor

St. Justine's Hospital

Who can join

Adults 3 Months to 18, any sex, with Community-acquired Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze.
Lassi ZS, Padhani ZA, Das JK, Salam RA, et al · · 2021 · cited 8× · PMID 33469915 · DOI 10.1002/14651858.cd009576.pub3

Verify or expand the search:

Other trials of Amoxicillin

Trials testing the same drug.

NCT07457385 — Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates · Phase 4 · not yet recruiting
NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting
NCT06921213 — Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis · Phase 2 · not yet recruiting
NCT06869850 — Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition · NA · recruiting

Other recruiting trials for Community-acquired Pneumonia

Currently open trials in the same condition.

NCT07164131 — Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lacta · Phase 4 · recruiting
NCT06577558 — Efficacy and Safety of SR1375 in Adult Patients With CAP · Phase 2 · recruiting
NCT06229288 — Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, an · Phase 3 · recruiting
NCT06125340 — Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy · Phase 4 · recruiting
NCT06114888 — Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics · NA · recruiting

Other St. Justine's Hospital trials

Trials by the same sponsor.

NCT04627766 — Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch · NA · recruiting
NCT06537622 — Best Practices Fo Early Diagnosis of Cerebral Palsy · NA · not yet recruiting
NCT06192368 — Virtual Reality Program to Reduce Stress in Neonatal Nurses · NA · completed
NCT06217510 — Pilot Project on the Automatic Design and 3D Printing of Adolescent Idiopathic Scoliosis Braces (Phase 1) · NA · unknown
NCT06173102 — Cranial Orthosis Therapy for Plagiocephaly: an RCT Pilot Study Comparing Cranial Orthosis to the Natural Course · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03031210 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Justine's Hospital
Last refreshed: 14 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03031210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing